Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126082581 | 12608258 | 1 | I | 20141223 | 20160719 | 20160729 | 20160729 | EXP | GB-LDELTA-NLLD0019622 | GB-TEVA-679589ACC | TEVA | 46.00 | YR | M | Y | 0.00000 | 20160729 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126082581 | 12608258 | 1 | PS | CISPLATIN. | CISPLATIN | 1 | U | 0 | |||||||||||
| 126082581 | 12608258 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | U | 0 | |||||||||||
| 126082581 | 12608258 | 3 | SS | ZAPONEX | CLOZAPINE | 1 | Oral | 300 MILLIGRAM DAILY; | 34787.5 | MG | Y | U | 0 | 300 | MG | TABLET | QD | ||
| 126082581 | 12608258 | 4 | SS | ZAPONEX | CLOZAPINE | 1 | Oral | 34787.5 | MG | Y | U | 0 | |||||||
| 126082581 | 12608258 | 5 | SS | ZAPONEX | CLOZAPINE | 1 | Oral | 34787.5 | MG | Y | U | 0 | 600 | MG | QD | ||||
| 126082581 | 12608258 | 6 | SS | ZAPONEX | CLOZAPINE | 1 | Oral | 34787.5 | MG | Y | U | 0 | |||||||
| 126082581 | 12608258 | 7 | C | GRANULOKINE | FILGRASTIM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126082581 | 12608258 | 1 | Laryngeal cancer |
| 126082581 | 12608258 | 2 | Laryngeal cancer |
| 126082581 | 12608258 | 7 | Neutropenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126082581 | 12608258 | DE |
| 126082581 | 12608258 | DS |
| 126082581 | 12608258 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126082581 | 12608258 | Drug effect incomplete | |
| 126082581 | 12608258 | Haemoglobin decreased | |
| 126082581 | 12608258 | Laryngeal cancer stage IV | |
| 126082581 | 12608258 | Leukopenia | |
| 126082581 | 12608258 | Lymphopenia | |
| 126082581 | 12608258 | Neutropenia | |
| 126082581 | 12608258 | Neutrophil count decreased | |
| 126082581 | 12608258 | Neutrophil count increased | |
| 126082581 | 12608258 | Platelet count decreased | |
| 126082581 | 12608258 | Platelet count increased | |
| 126082581 | 12608258 | Product use issue | |
| 126082581 | 12608258 | White blood cell count decreased | |
| 126082581 | 12608258 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126082581 | 12608258 | 1 | 201503 | 201504 | 0 | |
| 126082581 | 12608258 | 3 | 20150418 | 20150420 | 0 | |
| 126082581 | 12608258 | 4 | 20150421 | 20150422 | 0 | |
| 126082581 | 12608258 | 5 | 20081124 | 20150417 | 0 | |
| 126082581 | 12608258 | 6 | 20160320 | 0 | ||
| 126082581 | 12608258 | 7 | 201504 | 0 |